First Time Loading...

Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
SSE:600329

Watchlist Manager
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd Logo
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
SSE:600329
Watchlist
Price: 34.99 CNY 3.46% Market Closed
Updated: May 3, 2024

Wall Street
Price Targets

Price Targets Summary
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd

Wall Street analysts forecast Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd is 46.72 CNY with a low forecast of 46.26 CNY and a high forecast of 48.09 CNY.

Lowest
Price Target
46.26 CNY
32% Upside
Average
Price Target
46.72 CNY
34% Upside
Highest
Price Target
48.09 CNY
37% Upside
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd Competitors:
Price Targets
000919
Jinling Pharmaceutical Co Ltd
29% Upside
VETO
Vetoquinol SA
17% Upside
300723
Yipinhong Pharmaceutical Co Ltd
47% Upside
4016
Middle East Pharmaceutical Industries Company SJSC
26% Downside
GLAND
Gland Pharma Ltd
10% Upside
2070
Saudi Pharmaceutical Industries and Medical Appliances Corporation SJSC
4% Upside
300871
Wuhan Hvsen Biotechnology Co Ltd
27% Upside
CURA
Curaleaf Holdings Inc
29% Upside

Revenue
Forecast

Revenue Estimate
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd

For the last 8 years the compound annual growth rate for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd's revenue is 2%. The projected CAGR for the next 3 years is 13%.

2%
Past Growth
13%
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd

For the last 8 years the compound annual growth rate for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd's operating income is 10%. The projected CAGR for the next 3 years is 27%.

10%
Past Growth
27%
Estimated Growth
Estimates Accuracy
-8%
Average Miss

Net Income
Forecast

Net Income Estimate
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd

For the last 8 years the compound annual growth rate for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd's net income is 10%. The projected CAGR for the next 3 years is 20%.

10%
Past Growth
20%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd's stock price target?
Price Target
46.72 CNY

According to Wall Street analysts, the average 1-year price target for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd is 46.72 CNY with a low forecast of 46.26 CNY and a high forecast of 48.09 CNY.

What is Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd's Revenue forecast?
Projected CAGR
13%

For the last 8 years the compound annual growth rate for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd's revenue is 2%. The projected CAGR for the next 3 years is 13%.

What is Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd's Operating Income forecast?
Projected CAGR
27%

For the last 8 years the compound annual growth rate for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd's operating income is 10%. The projected CAGR for the next 3 years is 27%.

What is Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd's Net Income forecast?
Projected CAGR
20%

For the last 8 years the compound annual growth rate for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd's net income is 10%. The projected CAGR for the next 3 years is 20%.